Boros launches Boros OTC trading platform, open to users with holdings over $500,000
Foresight News reports that Boros, a funding rate trading platform under Pendle, has announced the launch of the Boros OTC trading platform. This platform provides an exclusive venue for funds and large-scale traders to hedge funding rate exposure in significant volumes, with customized terms and zero price impact. The platform is open to funds and traders holding positions above $500,000. Users can first submit their trading intentions via the OTC control panel; after passing verification, they may access the OTC section to create or review trading proposals. Once both parties accept a proposal, settlement occurs directly on-chain, and the positions will be added to the user's portfolio.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
NewAmsterdam Pharma appoints Robert Gunning principal accounting officer
Byrna Technologies director Rose P. Keravuori files initial beneficial ownership statement
Real Matters posts transcript of Q3 2026 earnings conference call
